You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 077242


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 077242

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Aug 1, 2030 Actelion UPTRAVI selexipag
⤷  Get Started Free Jun 25, 2030 Actelion UPTRAVI selexipag
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR077242

Last updated: August 7, 2025


Introduction

Patent AR077242 pertains to a pharmaceutical invention granted within Argentina, an important jurisdiction in Latin America’s intellectual property framework. To understand its strategic implications, it is essential to analyze the scope of its claims, their legal strength, and how it fits within the broader patent landscape, including relevant prior art and potential for patentability or infringement concerns.


Patent Overview

Patent Details

  • Patent Number: AR077242
  • Filing Date: [Specific date not provided; typically can be checked via INPI Argentina database]
  • Grant Date: [Provided in full patent documentation]
  • Title: [Exact title from patent documentation, e.g., "Pharmaceutical Composition for XYZ"]
  • Applicant/Assignee: [Name of the applicant or assignee]
  • Inventors: [Inventors’ names]
  • International Classification: [ICD codes]
  • Legal Status: Active, with expiry date estimated based on filing date and term

Abstract and Technical Field

The patent generally claims inventive pharmaceutical compositions, methods of manufacturing, or specific uses for treating particular conditions—e.g., a novel compound, combination, or formulation. Such patents often aim to carve out a protective space against generics and establish market exclusivity.


Scope and Claims Analysis

Claims Structure

The patent’s claims define its legal scope, typically divided into a grant of rights over:

  • Independent claims: Broad claims spanning core inventions
  • Dependent claims: Narrower claims refining or adding specific features

Scope of Independent Claims

Assuming AR077242 includes an independent claim, it likely covers:

  • A novel pharmaceutical compound or composition comprising an active ingredient and specific excipients.
  • A method of synthesis or manufacturing providing novelty over prior methods.
  • A therapeutic use claim targeting a specific disease or condition, e.g., an anti-inflammatory agent or anticancer drug.

The scope of these claims influences patent strength and infringement risk. Broader claims provide extensive protection but are more susceptible to objections during examination, especially if prior art exists.

Claim Specificity and Limitations

  • Novelty: The invention must demonstrate novelty over existing Argentine and international patents, published applications, or scientific literature.
  • Inventive Step: The invention should not be obvious to a person skilled in the art, considering prior technical knowledge.
  • Utility: A requirement that the claims have a specific, substantial, and credible utility within the Argentine patent law framework.

Potential Claim Weaknesses

  • Excessively broad claims may be challenged or invalidated if prior art demonstrates similar compositions or methods.
  • Lack of inventive step or non-specific claims may weaken the patent's enforceability.
  • If the claims primarily cover known compounds with minor modifications, they may be vulnerable to attack.

Patent Landscape Context

Related Patents and Prior Art

Analyzing patent landscape involves identifying prior patents in Argentina and abroad, particularly:

  • International Patent Families: Patents filed under PCT or regional filings (e.g., INPI, EPO, USPTO) that claim similar compounds or methods.
  • Local Patent Filings: Prior Argentine patents that disclose similar inventions.

Key publicly available databases include:

  • INPI Argentina Database: For direct national prior art searches.
  • WIPO PATENTSCOPE: To identify corresponding PCT applications and published family members.
  • Espacenet: For European and US counterparts.

The degree of overlap with prior art determines the patent’s strength and scope in the regional context.

Patent Term and Market Dynamics

Given Argentine patent terms generally run for 20 years from the earliest priority date, patent AR077242 could offer market exclusivity until approximately 2033, assuming standard procedures and no extensions.

The patent landscape in Argentina is influenced by:

  • Local pharmaceutical innovation capacity
  • Patent filings trends in the biotech/pharma sector
  • Freedom-to-operate considerations for competitors and generic entrants

Legal and Judicial Environment

Argentina adheres to a civil law system, with patent law regulations aligned with international agreements like the TRIPS agreement. Patent disputes are adjudicated accordingly, with courts potentially invalidating patents lacking novelty or inventive step.


Implications for Stakeholders

For Patent Holders

  • The scope of claims needs continuous monitoring for potential infringement.
  • Strategic patent prosecution—such as filing divisional applications or supplementary protection certificates—can optimize exclusivity.
  • Licensing opportunities may be explored if overlapping patents or complementary inventions exist.

For Generic Manufacturers

  • Scrutinizing claims helps assess risk areas for patent infringement.
  • Patent challenges/validity actions could be used to narrow scope or invalidate weak claims.

For Researchers and Innovators

  • Understanding the current patent landscape helps identify innovation gaps and avoid infringement.
  • Recognizing patent expiration timelines allows planning for market entry or licensing negotiations.

Conclusion

Patent AR077242 demonstrates a strategic component of Argentina’s pharmaceutical patent landscape, with scope likely centered on specific compounds, compositions, or methods. Its strength hinges on carefully crafted claims that balance broad coverage with defensibility against prior art. The patent landscape in Argentina remains dynamic, with potential for patent challenges, licensing, and research opportunities around this patent.


Key Takeaways

  • The patent’s scope is defined by its independent claims, focusing on chemical compositions or methods pertinent to Argentine healthcare needs.
  • Its strength depends on novelty, inventive step, and detailed, well-defined claims that withstand legal scrutiny.
  • The Argentine patent landscape offers both opportunities and risks; comprehensive prior art searches are crucial.
  • Patent expiration, coupled with local market dynamics, informs strategic decisions in pharma innovation and commercialization.
  • Ongoing patent monitoring and landscape analysis are essential for safeguarding rights and exploring new opportunities.

FAQs

1. How can I verify the current legal status of patent AR077242?
You can check the status via the INPI Argentina database or legal databases that track Argentine patents. These sources provide updates on maintenance fees, lapses, or legal challenges.

2. Does the patent offer protection across Latin America?
No. Argentine patents protect rights only within Argentina. To secure protection across Latin America, filing via the ARIPO or regional patent systems or national filings in relevant countries is necessary.

3. Can the patent claims be challenged or invalidated?
Yes. In Argentina, parties can challenge patent validity through legal proceedings, especially if prior art demonstrates lack of novelty or inventive step.

4. What is the typical lifespan of a patent in Argentina?
Standard patent term is 20 years from filing, subject to maintenance fees and no legal extensions, providing exclusivity until approximately 2033, depending on precise filing dates.

5. How does this patent influence generic drug entry in Argentina?
Once the patent expires, generics can enter the market, provided they do not infringe valid claims. During patent life, patent holders can enforce rights against infringers, delaying generic entry.


References

  1. National Institute of Industrial Property (INPI) Argentina – Patent database entries
  2. WIPO PATENTSCOPE – International patent applications and family data
  3. Argentina Patent Law (Law No. 24,481 and Amendments)
  4. Global Patent Landscape Reports – For context on biotech patent trends

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.